Autologous CIK Cells Infusion for the Treatment of Lung Cancer: a Randomized Controlled Study
NCT01498055 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120
Last updated 2012-03-22
Summary
To study the efficacy and safety of autologous CIK cells infusion for the treatment of lung cancer.
Conditions
Sponsors & Collaborators
-
Third Military Medical University
lead OTHER
Principal Investigators
-
Xiangdong Zhou · Southwest Hospital Third Military University
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-12-31
- Primary Completion
- 2013-12-31
- Completion
- 2013-12-31
Countries
- China
Study Locations
More Related Trials
-
Targeted Anti-CEA CAR-T Immunotherapy for Advanced Lung Cancer
NCT06992583 ·Status: RECRUITING ·Phase: PHASE1
-
Local Radiotherapy for Residual Tumor Lesions During the First-line Treatment
NCT05205226 ·Status: COMPLETED
-
A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China
NCT07316062 ·Status: RECRUITING
-
Evaluation of the Safety and Effectiveness of Percutaneous and Transbronchial Argon-helium Cryoablation
NCT05807022 ·Status: UNKNOWN ·Phase: NA
-
Change in NLR and Survival Among Advanced Lung Cancer Patients Receiving ICIs With Immunomodulator
NCT04352335 ·Status: COMPLETED
-
A Prospective Epidemiologic Study of ALK-Positive NSCLC in China
NCT02042105 ·Status: COMPLETED
-
Evaluation of Cyberknife Precision Radiation Delivery System for Unresectable Malignant Lung Cancer
NCT00238602 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Chemo-immunotherapy Induction Followed by Hypo-radiotherapy in LA-NSCLC(CHIC)
NCT05784142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Cryoablation with Robotic Bronchoscopy System in Patients with Lung Cancer
NCT06832956 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Study of Changes of Lymphocyte Subsets in Chemotherapy Course of Patients With Non-small Cell Lung Cancer
NCT02202655 ·Status: UNKNOWN
-
Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study
NCT05532527 ·Status: UNKNOWN ·Phase: NA
-
A Randomized Study of Primary Tumor Radiotherapy for Patients With Stage Ⅳ NSCLC
NCT04654520 ·Status: UNKNOWN ·Phase: NA
-
Real-World Immuno-Radiotherapy for Advanced NSCLC
NCT06747026 ·Status: COMPLETED
-
Immune Response to Immunotherapy in Lung Cancer: Study of Sputum and Blood Samples
NCT07163507 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Care Needs in Lung Cancer Patients Receiving Immunotherapy
NCT06433206 ·Status: RECRUITING
-
Established Lung Cancer Cell Line and Stroma Cell From Surgical Tissue
NCT01058811 ·Status: UNKNOWN
-
Bronchoscopy Screening for High-risk Population of Lung Cancer With Severe Smoking With Negative LDCT Screen
NCT04413669 ·Status: UNKNOWN ·Phase: NA
-
Application of ctDNA in the Evaluation of Curative Effect and Prognosis of SCLC Patients
NCT05066945 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety of Camrelizumab in Real-World Prospective Study
NCT04793139 ·Status: UNKNOWN
-
The Real Word Study of Albumin-binding Taxol for Lung Cancer Treatment
NCT03802409 ·Status: UNKNOWN
-
Effectiveness of Bronchoscopic Interventions for Malignant Airway Obstruction
NCT03326570 ·Status: COMPLETED
-
Transthoracic vs Transbronchial Radiofrequency Ablation for Lung Cancer
NCT06503744 ·Status: RECRUITING ·Phase: NA
-
A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments
NCT06617390 ·Status: COMPLETED
-
Clinical Study on Chimeric Antigen Receptor T Lymphocyte (CAR-T) Targeting CEA for the Treatment of CEA - Positive Advanced Lung Cancer
NCT06945523 ·Status: RECRUITING ·Phase: PHASE1
-
Interventional Ablation for Early-stage Lung Cancer
NCT07005999 ·Status: ACTIVE_NOT_RECRUITING